259 related articles for article (PubMed ID: 18283326)
1. The carcinogenic effects of radioiodine therapy for thyroid carcinoma.
de Vathaire F
Nat Clin Pract Endocrinol Metab; 2008 Apr; 4(4):180-1. PubMed ID: 18283326
[No Abstract] [Full Text] [Related]
2. Incidence of second primary malignancies during a long-term surveillance of patients with differentiated thyroid carcinoma in relation to radioiodine treatment.
Fallahi B; Adabi K; Majidi M; Fard-Esfahani A; Heshmat R; Larijani B; Haghpanah V
Clin Nucl Med; 2011 Apr; 36(4):277-82. PubMed ID: 21368600
[TBL] [Abstract][Full Text] [Related]
3. Assessment of female fertility and carcinogenesis after iodine-131 therapy for differentiated thyroid carcinoma.
Dottorini ME; Lomuscio G; Mazzucchelli L; Vignati A; Colombo L
J Nucl Med; 1995 Jan; 36(1):21-7. PubMed ID: 7799075
[TBL] [Abstract][Full Text] [Related]
4. Acute leukemias after treatment with radioiodine for thyroid cancer.
Roldán Schilling V; Fernández Abellán P; Domínguez Escribano JR; Rivas González C; Mut Barberá E; Calatayud Cendra R
Haematologica; 1998 Aug; 83(8):767-8. PubMed ID: 9793274
[TBL] [Abstract][Full Text] [Related]
5. Effects of I-131 therapy on gonads and pregnancy outcome in patients with thyroid cancer.
Sioka C; Fotopoulos A
Fertil Steril; 2011 Apr; 95(5):1552-9. PubMed ID: 21300333
[TBL] [Abstract][Full Text] [Related]
6. Radioiodine treated hyperthyroidism and thyroid carcinoma.
Appell R; Tsangaris N; Spiegel J
Am Surg; 1978 Aug; 44(8):537-40. PubMed ID: 707910
[TBL] [Abstract][Full Text] [Related]
7. Re: Cancer risk after iodine-131 therapy for hyperthyroidism.
Meyer MA
J Natl Cancer Inst; 1994 Jul; 86(13):1026-7. PubMed ID: 8007013
[No Abstract] [Full Text] [Related]
8. The use of radioactive iodine in patients with papillary and follicular thyroid cancer.
Wartofsky L; Sherman SI; Gopal J; Schlumberger M; Hay ID
J Clin Endocrinol Metab; 1998 Dec; 83(12):4195-203. PubMed ID: 9851751
[No Abstract] [Full Text] [Related]
9. Weighing shadows: can meta-analysis help define the risk-benefit ratio of RAI treatment for low-risk thyroid cancer patients?
Schneider AB; Viana MA; Ron E
Thyroid; 2009 May; 19(5):435-6. PubMed ID: 19415992
[No Abstract] [Full Text] [Related]
10. Radiation exposure and familial aggregation of cancers as risk factors for colorectal cancer after radioiodine treatment for thyroid carcinoma.
Rubino C; Adjadj E; Doyon F; Shamsaldin A; Abbas TM; Caillou B; Colonna M; Cecarreli C; Schvartz C; Bardet S; Langlois C; Ricard M; Schlumberger M; de Vathaire F
Int J Radiat Oncol Biol Phys; 2005 Jul; 62(4):1084-9. PubMed ID: 15990012
[TBL] [Abstract][Full Text] [Related]
11. Radioiodine therapy of metastatic lesions of differentiated thyroid cancer.
Luster M; Hänscheid H; Freudenberg LS; Verburg FA
J Endocrinol Invest; 2012; 35(6 Suppl):21-9. PubMed ID: 23014070
[TBL] [Abstract][Full Text] [Related]
12. [Mucoepidermoid carcinoma of the submandibular gland after high-dose radioiodine therapy: case report and review of the literature].
Henze M; Hittel JP; Elser H
Nuklearmedizin; 1998 Jan; 37(1):45-9. PubMed ID: 9467170
[TBL] [Abstract][Full Text] [Related]
13. Second Primary Cancer in Patients with Differentiated Thyroid Cancer: Does Radioiodine Play a Role?
Silva-Vieira M; Carrilho Vaz S; Esteves S; Ferreira TC; Limbert E; Salgado L; Leite V
Thyroid; 2017 Aug; 27(8):1068-1076. PubMed ID: 28614983
[TBL] [Abstract][Full Text] [Related]
14. Papillary and follicular thyroid carcinoma.
Schlumberger MJ
N Engl J Med; 1998 Jan; 338(5):297-306. PubMed ID: 9445411
[No Abstract] [Full Text] [Related]
15. Linear basal cell carcinomas: report of multiple sequential tumors localized to a radiotherapy port and review of the literature.
Chopra KF; Cohen PR
Tex Med; 1997 Jul; 93(7):57-9. PubMed ID: 9226992
[TBL] [Abstract][Full Text] [Related]
16. Acute promyelocytic leukaemia following radioiodine therapy.
Richards EM; Marcus RE
Clin Lab Haematol; 1993; 15(1):55-8. PubMed ID: 8472497
[No Abstract] [Full Text] [Related]
17. Childhood thyroid cancers and radioactive iodine therapy: necessity of precautious radiation health risk management.
Kumagai A; Reiners C; Drozd V; Yamashita S
Endocr J; 2007 Dec; 54(6):839-47. PubMed ID: 17938505
[TBL] [Abstract][Full Text] [Related]
18. Target therapies for radioiodine refractory advanced thyroid tumors.
Schlumberger M
J Endocrinol Invest; 2012; 35(6 Suppl):40-4. PubMed ID: 23014073
[TBL] [Abstract][Full Text] [Related]
19. Salivary gland malignancy and radioiodine therapy for thyroid cancer.
Klubo-Gwiezdzinska J; Van Nostrand D; Burman KD; Vasko V; Chia S; Deng T; Kulkarni K; Wartofsky L
Thyroid; 2010 Jun; 20(6):647-51. PubMed ID: 20470209
[TBL] [Abstract][Full Text] [Related]
20. Risk of second primary breast cancer after radioactive iodine treatment in thyroid cancer: a systematic review and meta-analysis.
Zhang Y; Liang J; Li H; Cong H; Lin Y
Nucl Med Commun; 2016 Feb; 37(2):110-5. PubMed ID: 26513055
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
